发明名称 Methods of treating migraine and compounds useful for such methods
摘要 This invention provides isolated nucleic acid molecules encoding human 5-HT1D receptors, isolated proteins which are human 5-HT1D receptors, vectors comprising isolated nucleic acid molecules encoding human 5-HT1D receptors, mammalian cells comprising such vectors, antibodies directed to human 5-HT1D receptors, nucleic acid probes useful for detecting nucleic acid encoding human 5-HT1D receptors, antisense oligonucleotides complementary to any sequences of a nucleic acid molecule which encodes a human 5-HT1D receptor, pharmaceutical compounds related to human 5-HT1D receptors, and nonhuman transgenic animals which express DNA which encodes a normal or a mutant human 5-HT1D receptor. This invention further provides methods for determining ligand binding, detecting expression, drug screening, and treatment involving the human 5-HT1D receptor.
申请公布号 US5935925(A) 申请公布日期 1999.08.10
申请号 US19950461812 申请日期 1995.06.05
申请人 SYNAPTIC PHARMACEUTICAL CORPORATION 发明人 WEINSHANK, RICHARD L.;BRANCHEK, THERESA;HARTIG, PAUL R.
分类号 A61K38/00;C07K14/705;C07K16/28;C12N15/12;C12N15/85;(IPC1-7):A01N37/18 主分类号 A61K38/00
代理机构 代理人
主权项
地址